Filing metadata

Accession number
0001209191-21-013897
Form type
Form 4
Filer
Stoke Therapeutics, Inc.
CIK
CIK 1623526
Filed
Feb 24, 2021
Reporting period
Feb 22, 2021
Description
Insider transaction

Explore SEC Filings Hub